Study on the utility of the short wavelength cut filter attached to the UVA 1(340~400nm) phototherapy device for Cutaneous T-cell Lymphomas.

Study on the utility of the short wavelength cut filter attached to the UVA 1(340~400nm) phototherapy device for Cutaneous T-cell Lymphomas. - Study on the utility of the short wavelength cut filter attached to the UVA 1(340~400nm) phototherapy device for CTCL.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000038988

Enrollment

Registered

2019-12-28

Start date

2019-12-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cutaneous T-Cell Lymphomas

Interventions

attached the short wavelength cut filter not attached the short wavelength cut filter

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 Cutaneous T-cell Lymphomas patients who are candidates for phototherapy. 2 Age between 16 and 65,written approval of patient. If the patient is a minor, the consent is needed from both the patient and the legal representative. 3 Patients who can understand the study and can issue consent to the study in writing.

Exclusion criteria

Exclusion criteria: 1 Patient who is not candidates for phototherapy. - Patient who will activate or recur malignant skin tumors. - Patient who has high carcinogenic risk(xeroderma pigmentosum, radiation therapy, internal use or touching career of arsenic etc.) - Patient who has remarkable photodermatosis(hereditary photodermatosis, albinism, porphyria, photosensitive collagen disease etc.) 2 Patient who participated other clinical studies or trials within 3 months of this study entry. 3 Pregnant or possibly pregnant women, or breastfeeding women. Women who wish to become pregnant during study participation. 4 Patient who is judged inappropriate to participate in the study by the investigator.

Design outcomes

Primary

Measure	Time frame
skin pigmentation of irradiation area	—

Countries

Japan

Contacts

Public ContactAkimichi Morita

Nagoya City University Graduate School of Medical Sciences Department of Geriatric and Environmental Dermatology

amorita@med.nagoya-cu.ac.jp052-853-8261

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026